SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001513162-19-000222
Filing Date
2019-10-24
Accepted
2019-10-24 19:11:06
Documents
1
Period of Report
2019-10-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2068
  Complete submission text file 0001513162-19-000222.txt   3608
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Issuer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 8071 Services-Medical Laboratories

Mailing Address 3150 ALMADEN EXPRESSWAY SUITE 250 SAN JOSE CA 95118
Business Address
Gottschalk Emily (Reporting) CIK: 0001791108 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37492 | Film No.: 191166982